STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

Inspire Medical Systems, Inc. to Present at the 2025 UBS Global Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

Inspire Medical Systems (NYSE: INSP) announced that its management will present at the 2025 UBS Global Healthcare Conference on Monday, November 10, 2025 at 11:45 a.m. ET. The presentation will be available via live webcast and a replay will be posted for two weeks in the Event Archive on Inspire’s investor website at https://investors.inspiresleep.com. The session covers the company’s recent business developments and investor outreach at the UBS conference.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction 1 Alert

+0.88% News Effect

On the day this news was published, INSP gained 0.88%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

MINNEAPOLIS, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will present at the 2025 UBS Global Healthcare Conference on Monday, November 10, 2025.

Inspire is scheduled to present at 11:45 a.m. Eastern Time. The presentation will be accessible via a live webcast here.

A webcast replay of the presentation will be available for two weeks following the presentation in the Event Archive section of Inspire’s Investor website at https://investors.inspiresleep.com.

About Inspire Medical Systems
Inspire is a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea. Inspire’s proprietary Inspire therapy is the first and only FDA, EU MDR, and PDMA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea.

For additional information about Inspire, please visit www.inspiresleep.com.

Investor and Media Contact
Ezgi Yagci
Vice President, Investor Relations
ezgiyagci@inspiresleep.com
617-549-2443


FAQ

When will Inspire Medical Systems (INSP) present at the 2025 UBS Global Healthcare Conference?

Inspire will present on Monday, November 10, 2025 at 11:45 a.m. Eastern Time.

How can investors watch Inspire Medical Systems (INSP) presentation on November 10, 2025?

The presentation will be available via a live webcast and a replay will be posted in the Event Archive on the investor website for two weeks.

Where is the replay of the INSP UBS conference presentation available?

A webcast replay will be available for two weeks in the Event Archive at https://investors.inspiresleep.com.

What time is Inspire Medical Systems (INSP) presenting in Eastern and local time on November 10, 2025?

The presentation is scheduled for 11:45 a.m. Eastern Time (adjust local time accordingly).

Will Inspire management cover financial results during the UBS Global Healthcare Conference presentation?

The announcement confirms a management presentation at the conference but does not specify detailed topics or financial disclosures.

Is there a cost to view Inspire Medical Systems (INSP) live webcast at the UBS conference?

The announcement indicates the presentation is accessible via a live webcast; no access fee is mentioned.
Inspire Medical

NYSE:INSP

INSP Rankings

INSP Latest News

INSP Latest SEC Filings

INSP Stock Data

3.99B
28.71M
1.14%
117.62%
7.94%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
GOLDEN VALLEY